Kestra Advisory Services’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Kestra Advisory Services's RPRX Position: Q2 2026 in Review
Kestra Advisory Services increased its Royalty Pharma (RPRX) stake by 46% in Q2 2026, buying an estimated $447K and bringing the position to 27,331 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1522.
Kestra Advisory Services first reported a position in RPRX in Q4 2024 and has held it in 7 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Kestra Advisory Services held 27,331 shares of Royalty Pharma worth $1.53M as of Q2 2026.
- Kestra Advisory Services bought 8,595 Royalty Pharma shares in Q2 2026, an estimated $447K.
- Royalty Pharma made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #1522 holding.
- Kestra Advisory Services first reported a position in Royalty Pharma in Q4 2024 and has held it in 7 quarters since.
- 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.